1.
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment
by Soy, Mehmet
Clinical rheumatology, 2020-05-30, Vol.39 (7), p.2085-2094
2.
Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis
by Baraliakos, Xenofon
Annals of the rheumatic diseases, 2014-04, Vol.73 (4), p.710-715
3.
The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis
by Boyle, D L
Annals of the rheumatic diseases, 2015-06, Vol.74 (6), p.1311-1316
4.
Use of Biologics in Rheumatoid Arthritis: Current and Emerging Paradigms of Care
by Curtis, Jeffrey R., MD, MPH
Clinical therapeutics, 2011, Vol.33 (6), p.679-707
5.
Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
by Misra, Durga Prasanna
Clinical rheumatology, 2020-04-10, Vol.39 (7), p.2055-2062
6.
Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha...
by Lan, Joung-Liang
Annals of the rheumatic diseases, 2011-10, Vol.70 (10), p.1719-1725
7.
Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conv...
by Baraliakos, X
Annals of the rheumatic diseases, 2014-10, Vol.73 (10), p.1819-1825
8.
Systematic Review of Tocilizumab for Rheumatoid Arthritis: A New Biologic Agent Targeting the Interleukin-6 Receptor
by Navarro-Millán, Iris, MD
Clinical therapeutics, 2012, Vol.34 (4), p.788-802.e3
9.
Cost-effectiveness of drug monitoring of anti-TNF therapy in inflammatory bowel disease and rheumatoid arthritis: a systematic review
by Martelli, Laura
Journal of Gastroenterology, 2016-09-24, Vol.52 (1), p.19-25
10.
Boswellia serrata extract attenuates inflammatory mediators and oxidative stress in collagen induced arthritis
by Umar, Sadiq
Phytomedicine (Stuttgart), 2014-05-15, Vol.21 (6), p.847-856
11.
A comprehensive review of rituximab therapy in rheumatoid arthritis patients
by Tavakolpour, Soheil
Clinical rheumatology, 2019-08-01, Vol.38 (11), p.2977-2994
12.
B-cell-directed therapies for autoimmune disease
by Dörner, Thomas
Nature reviews. Rheumatology, 2009-08, Vol.5 (8), p.433-441
13.
“Go upstream, young man”: lessons learned from the p38 saga
by Hammaker, D
Annals of the Rheumatic Diseases, 2010-01, Vol.69 (Suppl 1), p.i77-i82
14.
Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay
by Grabiec, Aleksander M
Annals of the Rheumatic Diseases, 2012-03, Vol.71 (3), p.424-431
15.
Effects of TNF antagonists on sperm characteristics in patients with spondyloarthritis
by Villiger, Peter M
Annals of the rheumatic diseases, 2010-10, Vol.69 (10), p.1842-1844
16.
IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy
by Verri, Waldiceu A
Annals of the Rheumatic Diseases, 2010-09, Vol.69 (9), p.1697-1703
17.
Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response
by Thurlings, R M
Annals of the rheumatic diseases, 2008-07, Vol.67 (7), p.917-925
18.
Corticosteroids and infliximab impair the performance of interferon-γ release assays used for diagnosis of latent tuberculosis
by Edwards, Alexander
Thorax, 2017-10, Vol.72 (10), p.946-949
19.
A novel disease-modifying osteoarthritis drug candidate targeting Runx1
by Yano, Fumiko
Annals of the rheumatic diseases, 2013-05, Vol.72 (5), p.748-753
20.
Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study
by Angel, Kristin
American journal of hypertension, 2012-06, Vol.25 (6), p.644-650
